The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), is pleased to announce that, further to its news release dated October 15, 2025, it has extended its existing agreement with Emerging Markets Consulting, LLC ("EMC") for the continued provision of investor relations and communication services by EMC for an additional six month term. Emerging Markets Consulting, LLC Based in Orlando, Florida, EMC...
2026-06-05 7:30 AM EDT
The Precision Peptide Company Inc. Signs Agreement with U.S.-Based 503A Sterile Compounding Pharmacy - Peptides to be 100% Compounded in the United States
Highlights Executed compounding agreement with a U.S.-based 503A sterile compounding pharmacy partner Compounding activities under the agreement expected to commence on Monday, June 1, 2026 All peptides under the agreement to be 100% compounded in the United States Designed to support prescription-based peptide preparation and fulfillment, including BPC-157 Up to approximately 25,000 prescriptions per day in fulfillment capacity available under the agreement, with reach across all U.S. states...
2026-06-02 7:00 AM EDT
The Precision Peptide Company to Exhibit as the Only Peptide Company at Dave Asprey's BEYOND Conference in Austin, Texas
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focuse
2026-05-28 7:30 AM EDT
The Precision Peptide Company Inc. Places Order for 20,000 BPC-157 Transdermal Patches
Vancouver, British Columbia--(Newsfile Corp. - May 26, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery syst
2026-05-26 7:30 AM EDT
The Precision Peptide Company (BPC) Expands on Exclusive 50/50 Revenue Share Peptide Partnership with MMA.INC (MMA)
Highlights Exclusive access to MMA.INC's global combat sports ecosystem1 of 5M+ social media followers, 530,000 user profiles and 800+ verified gyms across 16 countries MMA.INC's roster includes strategic advisors Conor McGregor (who was announced this week to headline UFC 329 against Max Holloway on July 11, 2026 in his first UFC appearance in five years2) and Donald Trump Jr., cofounder John Kavanagh and board director and UFC commentator Laura Sanko 50/50 net revenue share in Year 1,...
2026-05-21 7:30 AM EDT
The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch
Highlights The BPC-157 patch is a wearable, needle-free product, designed to remove the injection barrier that has historically limited consumer adoption of peptide products Results support The Precision Peptide Company Inc.'s continued progression of its lead product toward commercial launch Independent lab results confirm 95.5% chromatographic purity and a quantified 2.02 mg dose of BPC-157 per patch¹ Purity result clears the ≥95% threshold recognized across the peptide industry as the...
2026-05-19 7:00 AM EDT
The Precision Peptide Company's Chief Scientific Officer Justin Kirkland to Be Featured on The Human Upgrade with Dave Asprey
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that Justin Kirkland, Co-Founder and Chief Scientific Officer of the Company's wholly-owned subsidiary Amino Innovations, will be featured as a guest on an upcoming episode of The Human Upgrade with Dave Asprey. The Human Upgrade, hosted...
2026-05-14 7:30 AM EDT
The Precision Peptide Company Inc. Announces Exclusive Strategic Marketing Partnership with Mixed Martial Arts Group Limited
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has entered into an Exclusive Strategic Marketing Agreement (the "Strategic Marketing Agreement") dated May 8, 2026 with Mixed Martial Arts Group Limited ("MMA"), a New South Wales, Australia-based company. Under the Strategic...
2026-05-12 7:30 AM EDT
The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances
Vancouver, British Columbia--(Newsfile Corp. - May 7, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today provides an update on the development of its needle-free BPC-157 transdermal patch - a product designed to give consumers a frictionless route into the peptide category for the first time. The BPC-157 patch is currently in active testing, with...
2026-05-07 7:30 AM EDT
C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") a publicly traded wellness company focused on advanced peptide formulations and delivery systems, announces the receipt of approximately C$1.3 million from the exercise of outstanding warrants. The proceeds strengthen the Company's balance sheet and will be used to support the continued development and expansion of its Amino Innovations platform,...
2026-05-05 7:30 AM EDT
The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, announces the grant of restricted share units (the "RSUs") and incentive stock options (the "Options") pursuant to the Company's omnibus share incentive plan, as well as the issuance of common shares to settle outstanding indebtedness owed to a creditor...
2026-05-04 7:30 AM EDT
The Precision Peptide Company Announces Strategic Product Marketing Agreement
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into a strategic product marketing agreement with Raw Creation, a UK-headquartered creative agency ("Raw Creation"), to provide certain social media management, creative content, editorial, paid advertising and related marketing services to the Company (the "Agreement"). Pursuant to the Agreement, Raw...
2026-04-23 8:00 AM EDT
The Precision Peptide Company Applauds FDA Action Advancing Regulatory Clarity for Peptide Therapies
Vancouver, British Columbia--(Newsfile Corp. - April 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-based products and delivery systems, commends the U.S. Food and Drug Administration (FDA) for its recent actions to advance regulatory clarity surrounding peptide substances. The FDA's decision to remove several peptides from Category 2 of bulk drug substances and refer them to further evaluation...
2026-04-16 7:30 AM EDT
The Precision Peptide Company Announces Public Relations and Consulting Services Agreement
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into agreements with i) Think Ink Marketing Data and Email Services ("Think Ink") and ii) Ouimet Consulting Inc. ("Ouimet") to provide certain investor relations services to the Company. Think Ink The Company has entered into a public relations services agreement with Think Ink (the "Think Ink Agreement")....
2026-04-15 8:00 AM EDT
The Precision Peptide Company Launches New Corporate Website and Comments on Evolving U.S. Policy in Support of Peptide-Based Therapies
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-based products and delivery systems, today launched it's new corporate website: www.precisionpeptidecompany.com. The website will offer regular updates regarding company developments. Additionally, the Company is encouraged by recent indications from U.S. Health and Human Services Secretary, Robert...
2026-04-07 8:00 AM EDT
Pangea Announces Change of Auditor
Vancouver, British Columbia--(Newsfile Corp. - August 12, 2022) - Pangea Natural Foods Inc. (CSE: PNGA) ("Pangea" or the "Company"), a natural food company, announces that it has changed its auditors from Harbourside CPA LLP ("Former Auditor") to Baker Tilly WM LLP ("Successor Auditor"). The Former Auditor resigned as the auditor of the Company effective August 12, 2022, and the board of directors of the Company appointed the Successor Auditor as the Company's auditor effective August 12,...
2022-08-12 2:15 PM EDT